Sign in

NCT04794543Completed

Effects of Using E-Cigarettes on Lungs in People With HIV (HBS Ancillary)

Effects of E-Cigarettes on the Lung Metabolome in People Living With HIV

Source: ClinicalTrials.gov · Last updated 26 Aug 2024

Brief summary (registry, in English)

This is an ancillary study, thus participants will be recruited from participants in the HBS Study. This project acutely assesses the role of the e-cigarettes and vaping on lung health. The proposed work will inform the design of future studies to better understand vaping's health consequences and to test novel interventions to mitigate vaping's contribution to acute and/or chronic lung injury.

Status (registry)
Completed
Study type
Observational
Enrollment
23 (actual)
First submitted
4 Mar 2021
Start date
1 Apr 2022
Primary completion date
31 Aug 2023
Lead sponsor
Pennington Biomedical Research Center
Diseases
HIV
NCT number
NCT04794543

What you commit to

  • Study type: Observational
  • Participants enrolled: 23
  • From 1 Apr 2022 to the primary completion date, 31 Aug 2023
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • overt respiratory or oral cavity disease
  • acute illness in the past 4 weeks
  • active cancer
  • any other medical, psychiatric or behavioral factors that, in the judgment of the PI may interfere with study participation or ability to follow the protocol

Other

  • a pacemaker or other implanted electronic device
  • pregnant women, prisoners, cognitively-impaired subjects.
    • For this ancillary, the experimental group must actively use at least one of the following: e-cigarettes, e-liquid vapes, burning leaf tobacco cigarettes, or inhaled burning leaf marijuana (cannabis). The control group will have no use of e-cigarettes or vape or active smoking in the past year.
    • Participants must be willing to archive data and biological samples for future use.
    • Exclusion from the ancillary are:
  • active weight loss program

Criteria the registry did not label

  • This project is an ancillary study to the HBS Study. Inclusion Criteria for that IRB approved study are:
  • documented HIV-infection
  • in care at an HIV specialty clinic
  • age ≥ 18 years.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Pennington Biomedical Research Center
Coordinator of this site? Confirm its status
Baton RougeUnited StatesUnknown status
Lsuhsc-No
Coordinator of this site? Confirm its status
New OrleansUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.